Proton Intelligence Inc., a Vancouver, Canada-based developer of a continuous potassium monitoring (CKM™) platform, closed a $6.95m USD seed financing round.
Backers included SOSV, We Venture Capital, Tenmile, LongeVC, 15th Rock, Exor, and Trampoline Venture Partners.
Led by Dr. Sahan Ranamukhaarachchi, Founder and CEO, Proton Intelligence provides the CKM™ platform, which is designed to transform the management of cardio-kidney-metabolic diseases by providing clinicians and patients with data about potassium levels on-demand. Proton’s CKM™ technology aims to provide providers and patients accurate, remote, continuous potassium levels allowing precise treatment of patients suffering from kidney disease or heart failure.
Proton Intelligence has initiated clinical studies assessing the performance of CKM™ in people living with severely impaired kidney function such as the underserved population living with end-stage renal disease (ESRD) or chronic kidney disease (CKD).
The company is headquartered in Vancouver, Canada, with R&D operations in Melbourne, Australia.
FinSMEs
02/01/2025